Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30050035 | 1.00 | GPR3 (0.54) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL30618063 | 0.90 | KDM4E (0.50) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL3056634 | 0.89 | GPR3 (0.54) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL30913876 | 0.89 | GPR3 (0.54) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL13766548 | 0.82 | GPR3 (0.56) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL10970273 | 0.81 | GPR3 (0.54) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL20712208 | 0.80 | MAPT (0.41) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15449499 | 0.80 | ALDH1A1 (0.41) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL9970460 | 0.79 | GPR3 (0.52) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL24742469 | 0.79 | KDM4E (0.42) | ALDH1A1MAPTRAB9AHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3392258-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-07-15 | — | — | EP | disclosed |
| US-9773980-B2 | Organic electroluminescent device | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-09-26 | — | — | US | disclosed |
| US-9773980-B2 | Organic electroluminescent device | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-09-26 | — | — | US | disclosed |
| US-9773980-B2 | Organic electroluminescent device | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-09-26 | — | — | US | disclosed |
| US-20140299853-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20140299853-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20140299853-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-10-09 | — | — | US | disclosed |
| EP-2787054-A1 | Organic electroluminescent device | Kabushiki Kaisha Toshiba (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-7663301-B2 | for use as robust red organic phosphors | GENERAL ELECTRIC COMPANY (US) | 2010-02-16 | — | — | US | disclosed |
| WO-2006076247-A2 | PHOSPHORESCENT FLUORENE, ANTHRACENE AND/OR THIOPHENE SUBSTITUTED METALLO- PORPHYRINS AND RELATED COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060152149-A1 | Porphyrin compositions | GENERAL ELECTRIC COMPANY (US) | 2006-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060152149-A1 | Porphyrin compositions | ACP1, MMS19, MVD | GPR3 3994/4885ALDH1A1 1882/4885MAPT 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.